/Investor DB

OMX Ventures — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Delixdelixtherapeutics.cominSep 2021 · $70M

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)

Co-investorsArtis VenturesBailey Venture PartnersCasa Verde CapitalDolby Family VenturesGaingelsIaso Ventures+9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.